Pulling SEC filings + quote and writing the call…

Solana Co
Next earnings Aug 12, 2026 · consensus $-0.02 EPS, $3.67M rev
Last earnings -3.8% on 2026-05-15
A pivoted micro-cap medical-device shell turned Solana treasury vehicle — a diluted, volatile crypto proxy, not an investable operating business.
P/S (market cap / revenue) 176.8 · FY2025
HSDT is no longer an operating company in any meaningful sense — it is a 'digital asset treasury' (DAT) whose stated objective is to 'maximize SOL per share' by raising capital and holding Solana tokens, bolted onto a fading neurotech business (the PoNS device) that the filing itself relegates to 'to a lesser extent.' The financials confirm the transformation: total assets exploded +8,480% to $304M and equity +28,314% to $301M, driven almost entirely by the September 2025 PIPE offerings used to buy SOL, while the actual underlying business generated just $548K of revenue (FY2025, +5.4% YoY). At a $96.9M market cap that is a P/S of 176.8 — the multiple is meaningless because there is no real revenue engine; what you are buying is a basket of crypto and a cash burn, not a going concern.
The income statement is internally noisy and alarming. Operating income was -$244M and FY2025 net income was -$40.9M (-248% YoY), with a cumulative deficit of -$213M, while operating cash flow ran -$16.5M. The 'gross margin' of 1,007% and operating margin of -44,496% are artifacts of fair-value/impairment swings on digital assets against a tiny revenue base — they are not analyzable as a business. Critically, shares outstanding ballooned +798% in a single year to fund the SOL buys; existing holders were massively diluted, and the DAT model explicitly relies on issuing more stock and pursuing 'onchain opportunities' to grow, so further dilution is the strategy, not a risk to be avoided.
Is HSDT a buy? The one-page verdict, explained →
AVOID means we wouldn't engage at all — if expressing the short side anyway, only with capped risk.
Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $493K | $778K | $605K | $520K | $548K |
| Gross profit | $224K | $324K | $61.0K | -$62.0K | $5.52M |
| Operating income | -$18.1M | -$15.5M | -$12.4M | -$13.9M | -$244M |
| Net income | -$18.1M | -$14.1M | -$8.85M | -$11.7M | -$40.9M |
| Diluted EPS | -$7.38 | -$52.13 | -$14.56 | -$3,282.26 | -$1.85 |
| Net margin | -3677.9% | -1808.7% | -1462.8% | -2258.1% | -7461.7% |
10-year statements — income, cash flow, balance sheet & CSV export →
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Entered a new material agreement; exhibits filed (likely financing or SOL deal)
Reported annual-meeting voting results plus a routine other-events disclosure
Q1-FY26 10-Q: SOL treasury on books, equity ~$301M, but losses persist
Q1-FY26 10-Q: SOL treasury on books, equity ~$301M, but losses persist
Disclosed unregistered share sales (dilution) to fund SOL; Reg FD update
Announced a management or board change (Item 5.02)
Disclosed an executive/board appointment or departure with exhibits
Filed annual-meeting proxy (board elections, pay, routine proposals)
FY25 10-K: pivoted to Solana treasury via ~$300M PIPE; net loss widened to $41M
Sources: SEC EDGAR (CIK 0001610853, latest 10-Q filed 2026-05-15) · EODHD · Proprietary analysis · as of 6/30/2026, 11:58:03 AM.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 30, 2026, 7:58 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
| 2026-06-02 | Jiang Cosmo Yi Director | Exercise | 1.01M @ $0.00 | $1.01K |
| 2026-06-02 | Jiang Cosmo Yi Director | Tax | 610.00 @ $1.65 | $1.01K |
| 2026-05-21 | Mello Sergio Director | Award | 6.36K | |
| 2026-05-21 | Lee Michel Kai Tai Director | Award | 6.36K | |
| 2026-05-21 | STRAW EDWARD M Director | Award | 6.36K | |
| 2026-05-21 | Walter Blane Director | Award | 6.36K | |
| 2026-05-11 | Fusion Summer Ltd 10% owner | Disposed (J) | 1.45M | |
| 2026-05-11 | Chee Choon Wee Executive Chairman | Exercise | 1.11M |
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
1195 tracked peers · median